Results 41 to 50 of about 2,731,118 (178)

Genomic and Phenotypic Evolution of Tigecycline-Resistant Acinetobacter baumannii in Critically Ill Patients

open access: yesMicrobiology Spectrum, 2022
Acinetobacter baumannii is an important opportunistic pathogen of nosocomial infections. A. baumannii presently exhibits increasing antibiotic resistance, which poses great challenges to public health. The occurrence of tigecycline-resistant A. baumannii
Jiangang Zhang   +8 more
doaj   +1 more source

Effect of ramR loss-of-function insertion on tigecycline resistance in clinical isolates of carbapenem-resistant Klebsiella pneumoniae

open access: yesJournal of Global Antimicrobial Resistance, 2020
Objectives: Tigecycline is an antibacterial agent restricted for use against carbapenem-resistant Klebsiella pneumoniae (CRKP). This study aimed to identify the tigecycline resistance mechanism in clinical CRKP isolates obtained from a 60-year-old ...
Yihan Mao   +4 more
doaj   +1 more source

Molecular Analysis of Tigecycline Resistance in Carbapenem-Resistant Enterobacterales (CRE) in Mthatha and Surrounding Hospitals. [PDF]

open access: yesAntibiotics (Basel)
The emergency of carbapenem-resistant Enterobacterales is prevalent and poses a significant threat to health systems worldwide. The European Center for Disease Control and Prevention has reported a mortality rate of about 50% in patients with CRE ...
Vumba L, Singh R, Vasaikar S.
europepmc   +2 more sources

Comment on: High tigecycline resistance in multidrug-resistant Acinetobacter baumannii [PDF]

open access: yesJournal of Antimicrobial Chemotherapy, 2007
1. Seaman PF, Ochs D, Day MJ. Comment on: Triclosan resistance in methicillin-resistant Staphylococcus aureus expressed as small colony variants: a novel mode of evasion of susceptibility to antiseptics. J Antimicrob Chemother 2007; doi:10.1093/jac/dkm118. 2. Bayston R, Ashraf W, Smith T.
Visanu, Thamlikitkul   +2 more
openaire   +2 more sources

Emergence of Colistin Resistance in Carbapenem-Resistant Hypervirulent Klebsiella pneumoniae Under the Pressure of Tigecycline

open access: yesFrontiers in Microbiology, 2021
Colistin and tigecycline are the last options against carbapenem-resistant hypervirulent Klebsiella pneumoniae (CR-hvKP). Intersecting resistance determinants have been detected between these antibiotics; however, there is only limited evidence of such ...
Yawei Zhang   +7 more
doaj   +1 more source

Identification of Novel tet(X3) Variants Resistant To Tigecycline in Acinetobacter Species

open access: yesMicrobiology Spectrum, 2022
The emergence of the tet(X) gene is a severe challenge to global public health security, as clinical tigecycline resistance shows a rapidly rising trend. In this research, we identified two tigecycline-resistant Acinetobacter sp. strains containing seven
Yumeng Cheng   +5 more
doaj   +1 more source

The Plasmid-Borne tet(A) Gene Is an Important Factor Causing Tigecycline Resistance in ST11 Carbapenem-Resistant Klebsiella pneumoniae Under Selective Pressure

open access: yesFrontiers in Microbiology, 2021
The emergence and prevalence of tigecycline-resistant Klebsiella pneumoniae have seriously compromised the effectiveness of antimicrobial agents in the treatment of infections.
Juan Xu   +4 more
doaj   +1 more source

First emergence of acrAB and oqxAB mediated tigecycline resistance in clinical isolates of Klebsiella pneumoniae pre-dating the use of tigecycline in a Chinese hospital. [PDF]

open access: yesPLoS ONE, 2014
Tigecycline is one of the few therapeutic options for treating infections caused by some multi-drug resistant pathogens, such as Klebsiella pneumoniae. However, tigecycline-resistant K. pneumoniae has been discovered recently in China. From 2009 to 2013,
Xue Zhong   +5 more
doaj   +1 more source

Once-a-week tigecycline for the treatment of drug-resistant TB [PDF]

open access: yesJournal of Antimicrobial Chemotherapy, 2019
MDR-TB and XDR-TB have poor outcomes.To examine the efficacy of tigecycline monotherapy in the hollow fibre system model of TB.We performed pharmacokinetic/pharmacodynamic studies using tigecycline human-like concentration-time profiles in the hollow fibre system model of TB in five separate experiments using Mycobacterium tuberculosis in log-phase ...
Devyani Deshpande   +8 more
openaire   +2 more sources

1456. Resistance Mechanisms of Tigecycline in Enterococcus faecalis [PDF]

open access: yesOpen Forum Infectious Diseases, 2020
Abstract Background Enterococcus faecalis have been regarded as one of the leading causes of the nosocomial infections worldwide. Tigecycline (TGC) is considered as a choice of last resort for the treatment of infections caused by multidrug-resistant E.
Bai, Bing   +4 more
openaire   +1 more source

Home - About - Disclaimer - Privacy